Jon Christianson Sells 528 Shares of Palomar (NASDAQ:PLMR) Stock

Palomar Holdings, Inc. (NASDAQ:PLMR) President Jon Christianson sold 528 shares of the firm’s stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $127.75, for a total value of $67,452.00. Following the transaction, the president directly owned 66,970 shares in the company, valued at $8,555,417.50. This trade represents a 0.78% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Jon Christianson also recently made the following trade(s):

• On Monday, July 20th, Jon Christianson sold 3,000 shares of Palomar stock. The stock was sold at an average price of $139.50, for a total transaction of $418,500.00.
• On Thursday, July 2nd, Jon Christianson sold 6,863 shares of Palomar stock. The shares were sold at an average price of $139.50, for a total transaction of $957,388.50.

Palomar Stock Up 0.9%

Palomar stock opened at $130.09 on Friday. Palomar Holdings, Inc. has a 52 week low of $100.81 and a 52 week high of $147.62. The stock has a market cap of $3.42 billion, a price-to-earnings ratio of 17.49 and a beta of 0.40. The company’s 50-day moving average price is $130.76 and its two-hundred day moving average price is $123.92. The company has a current ratio of 0.50, a quick ratio of 0.50 and a debt-to-equity ratio of 0.30.

Palomar (NASDAQ:PLMR) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $2.36 earnings per share for the quarter, topping analysts’ consensus estimates of $2.19 by $0.17. The company had revenue of $314.42 million during the quarter, compared to analyst estimates of $621.52 million. Palomar had a net margin of 18.61% and a return on equity of 23.28%. During the same period in the prior year, the business posted $1.76 EPS. On average, analysts expect that Palomar Holdings, Inc. will post 9.21 EPS for the current fiscal year.

Palomar Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 2nd. Investors of record on Wednesday, August 19th will be issued a dividend of $0.45 per share. The ex-dividend date of this dividend is Wednesday, August 19th. This represents a $1.80 annualized dividend and a yield of 1.4%. Palomar’s payout ratio is presently 24.19%.

Palomar News Summary

Here are the key news stories impacting Palomar this week:

• Positive Sentiment: Strong premium growth and expansion in specialty insurance are expected to support Palomar’s earnings momentum. Analysts’ average price target of $162.75 and recent target increases reinforce the bullish view. Can Strong Premium Growth Sustain Palomar’s Earnings Momentum?
• Positive Sentiment: Dowling & Partners expressed a positive view of Palomar’s fiscal 2026 earnings outlook, adding to expectations for continued profit growth. DOWLING & PARTN Has Positive View of Palomar FY2026 Earnings
• Positive Sentiment: Palomar’s latest quarterly results provide fundamental support: earnings per share of $2.36 exceeded the $2.19 consensus estimate, while profitability and return on equity remained strong.
• Neutral Sentiment: Several insiders, including the president, CFO and Jonathan Knutzen, sold relatively small portions of their holdings to cover tax withholding on vested equity awards. Because the transactions were not discretionary sales, they are less negative than typical insider selling, though they may limit near-term sentiment.
• Neutral Sentiment: Palomar declared a quarterly dividend of $0.45, equivalent to $1.80 annually and a yield of approximately 1.4%, providing modest shareholder support.
• Negative Sentiment: Competitive pricing could reduce premium profitability, while a higher combined ratio would pressure underwriting margins. These risks may temper the market’s response to otherwise strong growth expectations. Can Strong Premium Growth Sustain Palomar’s Earnings Momentum?

Institutional Investors Weigh In On Palomar

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Geneos Wealth Management Inc. bought a new stake in shares of Palomar during the 4th quarter worth $32,000. Kestra Advisory Services LLC acquired a new stake in shares of Palomar during the fourth quarter worth $33,000. Rockefeller Capital Management L.P. lifted its holdings in shares of Palomar by 81.5% during the fourth quarter. Rockefeller Capital Management L.P. now owns 294 shares of the company’s stock valued at $40,000 after purchasing an additional 132 shares during the last quarter. Quantbot Technologies LP purchased a new stake in shares of Palomar during the second quarter valued at $43,000. Finally, Frazier Financial Advisors LLC acquired a new position in shares of Palomar in the 4th quarter valued at $54,000. Institutional investors and hedge funds own 90.25% of the company’s stock.

Analysts Set New Price Targets

PLMR has been the topic of several research analyst reports. Zacks Research cut Palomar from a “strong-buy” rating to a “hold” rating in a research report on Friday, May 15th. Weiss Ratings upgraded Palomar from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, June 18th. Piper Sandler raised their target price on Palomar from $132.00 to $165.00 and gave the company an “overweight” rating in a research note on Wednesday, July 15th. Evercore set a $152.00 target price on Palomar in a report on Friday, July 10th. Finally, Keefe, Bruyette & Woods boosted their price target on shares of Palomar from $166.00 to $167.00 and gave the stock an “outperform” rating in a research report on Monday, August 10th. Four research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $162.75.

About Palomar

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.